top of page
AUTOIMMUNITY BIOSOLUTIONS NEWS
ABS announced key appointments to its leadership team, including Richard Polisson, MD, MHSc, Chief Medical Officer, and Jen Beachell, MBA, Chief Business Officer.
Autoimmunity BioSolutions raises $2M Series Seed to advance development of a next generation, immuno-corrective therapy for autoimmune disease treatment
Autoimmunity BioSolutions raises $2M Series Seed to advance development of a next generation, immuno-corrective therapy for autoimmune disease treatment
bottom of page